The promise of nanotechnology for solving clinical problems in breast cancer
โ Scribed by Stephen R. Grobmyer; David L. Morse; Bradley Fletcher; Luke G. Gutwein; Parvesh Sharma; Vijay Krishna; Susan C. Frost; Brij M. Moudgil; Scott C. Brown
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 267 KB
- Volume
- 103
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Periodic screening for cancer of the breast using mammography as well as clinical examination is being conducted by the Health Insurance Plan in a large random sample of women aged 40 to 64 years. A similar group of women has been assigned as controls. The long term objective is to determine whether
The potential for the use of hyperthermia in the treatment of cancer is based on a strong and compelling biologic rationale. In the laboratory it has been shown in quantitative assays both in vitro and in vivo that (1) hyperthermia is cytotoxic to tumor cells as a function of time at temperatures ab
Estrogens are the major hormones supporting the growth of human breast cancer. Aromatization of androgen precursors in peripheral tissues, including the breast cancer itself, is the major source of estrogens in postmenopausal women. Therefore, inhibition of the aromatase enzyme offers an effective m